ONGC, Biocon, and Hyundai Motor India, highlighting their potential for robust growth and value creation in the next 1 year.
CLSA has upgraded ONGC to «High Conviction Overweight-PF,» citing multiple production and realization triggers, alongside attractive valuations and a strong dividend yield.
Jefferies has revised its stance on Biocon to «Hold,» driven by positive regulatory developments and improved growth visibility in its biologics business.
Meanwhile, Citi has initiated coverage on Hyundai Motor India with a «Buy» rating, emphasizing its diverse product lineup, export potential, and planned capacity expansions.
Stock Trading
Masterclass on Value Investing and Company Valuation
Stock Trading
Market 104: Options Trading: Kickstart Your F&O Adventure
By — Saketh R, Founder- QuickAlpha, Full Time Options Trader
Stock Trading
Technical Analysis for Everyone — Technical Analysis Course
By — Abhijit Paul, Technical Research Head, Fund Manager- ICICI Securities
Stock Trading
Stock Markets Made Easy
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Renko Chart Patterns Made Easy
By — Kaushik Akiwatkar, Derivative Trader and Investor
Stock Trading
Market 101: An Insight into Trendlines and Momentum
By — Rohit Srivastava, Founder- Indiacharts.com
Stock Trading
Markets 102: Mastering